Delivery Order SPE2DB20D1109-SPE2DB25FP54X
- Not listed
- The Defense Logistics Agency awarded a $26,378.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. This firm fixed-price delivery order, valued at $14,390.73, is classified as a non-set-aside competition and is scheduled for completion by August 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,849.46 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of August 11, 2025. This non-competitive delivery order was issued on August 8, 2025, with firm fixed pricing. The award represents a routine pharmaceutical procurement through AmerisourceBergen's established supply chain, with performance to be executed at the company's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 MG, with a ceiling value of $13,338.54 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and has an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.96 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg on August 14, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance occurring at the contractor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron ODT 4 mg, a commonly used anti-nausea medication, under a firm fixed-price contract valued at $1,842.70. The contract, which became effective on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $23,599.21 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in medical settings. This firm fixed price delivery order, awarded on July 24, 2025, with completion targeted for July 25, 2025, represents a child order issued under a larger contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and carries a ceiling value of $43,367.61. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $1,962.99 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,595.23 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 MG tablets (30-count). This competitive, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP54XDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,077.32 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in medical settings. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems and other federal agencies worldwide. The company's non-competitive award history and established role as a critical pharmaceutical distributor for federal medical procurement underscore its position as a primary vendor for defense healthcare supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/11/25 |